[PTGX] YoY Quarter Result on 30-Jun-2019 [#Q2]

Stock
[PTGX] Protagonist Therapeutics, Inc.
Announcement Date
07-Aug-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- -106.86%
YoY- -236.77%
Quarter Report
PTGX's Result
PTGX's Financial Summary
View:
Show?
Quarter Result
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Revenue 859 2,265 6,217 -8,189 11,674 0 0 -
PBT -41,037 -30,842 -18,292 -30,803 -8,663 -14,979 -7,098 33.95%
Tax -406 -57 1,129 -1,629 0 0 -27 57.07%
NP -40,631 -30,842 -19,421 -29,174 -8,663 -14,979 -7,098 33.73%
Tax Rate - - - - - - - -
Total Cost 41,490 33,107 25,638 20,985 20,337 14,979 7,098 34.19%
Ratio Analysis
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
NP Margin -4,730.03 -1,361.68 -312.39 356.26 -74.21 0.00 0.00 -
Per Share
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
EPS -0.83 -0.69 -0.59 -1.18 -0.41 -0.89 -0.43 11.57%
EPS Diluted -0.83 -0.69 -0.59 -1.18 -0.41 -0.89 -0.43 11.57%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.